Cure My Disease

Don't miss your cure!

 Log in / Sign up

Quick hepatitis c test during mammograms could catch hidden cases

NCT ID NCT05067374

Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study offered a rapid hepatitis C test to 1,500 women aged 50-74 who were already coming in for breast cancer screening in Montpellier, France. The goal was to see how many women would agree to the extra test and how many had undiagnosed hepatitis C. Women who tested positive were then connected to care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
rapid diagnostic orientation test (TROD) for hepatitis C
What this could lead to
If successful, this approach could help find undiagnosed hepatitis C cases in older women during routine breast cancer screening, supporting elimination goals.
What could go wrong
This is a completed observational study, not a treatment trial. It only tests screening feasibility, not whether finding cases improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,500 people

The number who actually took part.

Started

Mar 2022

Finished

Feb 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women participating in the organized systematic breast cancer screening

Ages

50 to 74 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \- Women aged 50-74 inclusive * Doing a breast cancer screening * Able to understand and complete a questionnaire on their own or with the help of a third party * Able to understand the study and follow the protocol * Having signed the consent form * With social security plan Exclusion Criteria: * \- Cannot sign the consent or follow the protocol * Under French legal protection measure (sauvegarde de justice, tutelle or curatelle)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm hepatitis C virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Hepatitis C

Contacts and locations

Locations

  • Beausoleil private clinic

    Montpellier, Occitanie, 34000, France

  • Lapeyronie radiology ward (Montpellier University hospital)

    Montpellier, Occitanie, 34000, France

  • Le Millénaire private clinic

    Montpellier, Occitanie, 34000, France

  • Victor Hugo Center

    Montpellier, Occitanie, 34000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.